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ABSTRACT
Parkinson’s disease is associated with mitochondrial decline in
dopaminergic neurons of the substantia nigra. One of the genes
linked with the onset of Parkinson’s disease, DJ-1/PARK7, belongs
to a novel glyoxalase family and influences mitochondrial activity. It
has been assumed that glyoxalases fulfill this task by detoxifying
aggressive aldehyde by-products of metabolism. Here we show that
supplying either D-lactate or glycolate, products of DJ-1, rescues
the requirement for the enzyme in maintenance of mitochondrial
potential. We further show that glycolic acid and D-lactic acid can
elevate lowered mitochondrial membrane potential caused by
silencing PINK-1, another Parkinson’s related gene, as well as
by paraquat, an environmental toxin known to be linked with
Parkinson’s disease. We propose that DJ-1 and consequently its
products are components of a novel pathway that stabilizes
mitochondria during cellular stress. We go on to show that
survival of cultured mesencephalic dopaminergic neurons,
defective in Parkinson’s disease, is enhanced by glycolate and D-
lactate. Because glycolic and D-lactic acids occur naturally, they are
therefore a potential therapeutic route for treatment or prevention of
Parkinson’s disease.
KEY WORDS: Parkinson’s disease, Glyoxalase, D-lactate,
Glycolate, Mitochondrial membrane potential
INTRODUCTION
Parkinson’s disease is caused by inexorable deterioration of
dopaminergic neurons from the substantia nigra (Corti et al.,
2011). Although little is known about the onset of Parkinson’s
disease, one clue is that a number of genes associated with it are
linked to mitochondrial activity (Corti et al., 2011; Federico et al.,
2012). One of such genes is DJ-1/PARK7, which was originally
reported as an oncogene (Nagakubo et al., 1997), and associated
with familial Parkinson’s disease (Bonifati et al., 2003). DJ-1
deficiency was reported to lead to abnormal mitochondrial
morphology and dynamics, increased sensitivity to oxidative
stress, decreased mitochondrial membrane potential, and opening
of the mitochondrial permeability transition pore (Irrcher et al.,
2010; Giaime et al., 2012). DJ-1 protein exerts its neuroprotective
function against oxidative stress primarily in mitochondria (Junn
et al., 2009). Although DJ-1 is predicted and reported to have
activity as protease and chaperon (Mizote et al., 1996; Bonifati
et al., 2003; Shendelman et al., 2004; Gautier et al., 2012), it is
unclear whether these activities contribute to mitochondrial
fitness.
DJ-1 was recently reported to belong to a novel glyoxalase family
(Lee et al., 2012). Glyoxalases are enzymes that can transform
2-oxoaldehydes glyoxal and methylglyoxal into corresponding
2-hydroxyacids glycolate and D-lactate, respectively. Glyoxal and
methylglyoxal covalently react with proteins or lipids to form
advanced glycation end-products (AGEs), which are implicated
in neurodegenerative diseases including Parkinson’s disease
(Castellani et al., 1996; Li et al., 2012). So far, two systems of
glyoxalases have been described: 1) Glutathione-dependent Glo I
and Glo II systems (Thornalley, 2003) and 2) cofactor-independent
Glo III system (DJ-1) (Misra et al., 1995; Lee et al., 2012). Because
substrates of glyoxalases are aggressive aldehydes produced
by oxidation of glucose during glycolysis (methylglyoxal) and
peroxidation of fatty acids (glyoxal), it is assumed that the major
function of glyoxalases is to detoxify aldehyde by-products of
metabolism (Thornalley, 2003). However, this view has not always
been prevalent. Glyoxalases, and their corresponding products (e.g.
D-lactate) were considered major components of glycolysis (Ray
and Ray, 1998). With the elucidation of the Embden–Meyerhof–
Parnas pathway of glycolysis, production of D-lactate was
considered an artifact of a biochemical procedure or an undesired
side product of glycolysis. Thus, the cellular role of the products of
glyoxalases remains unclear.
Here we show that in both HeLa cells and C. elegans, the
products of DJ-1, glycolate and D-lactate, are required to maintain
mitochondrial membrane potential. Remarkably, D-lactate and
glycolate increase in vitro survival of primary dopaminergic
neurons from Parkinson’s model mice embryos. We propose that
the products of the glyoxalases are components of a novel pathway
that maintain high mitochondrial potential during cellular stress,
and that production of glycolate and D-lactate is required to
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prevent degeneration of dopaminergic neurons in the substantia
nigra.
RESULTS
Recently we reported that the Caenorhabditis elegans dauer
larva, an arrested stage specialized for survival in adverse
conditions, is resistant to severe desiccation (Erkut et al., 2011).
However, this requires a preconditioning step at a mild
desiccative environment (98% relative humidity) to prepare the
organism for harsher desiccation conditions (60% relative
humidity). We found that during preconditioning, glyoxalase
genes djr-1.2 and glod-4 were very strongly upregulated (Erkut
et al., 2013) (Fig. 1A,B; supplementary material Fig. S1). We
asked whether glyoxalases are required to survive desiccation
stress. To address this question, we first produced djr-1.1;djr-1.2
double mutant missing both DJ-1 homologs (DDdjr), and djr-
1.1;djr-1.2;glod-4 triple mutant defective additionally in Glo I/II
system (Dglo) (see Materials and Methods). Dauer larvae of these
mutants were first preconditioned, and then further desiccated at
60% relative humidity. Subsequently they were rehydrated and
measured for their survival rate (Fig. 1A,C). The Dglo mutant
showed significantly increased sensitivity to 60% relative
humidity compared to wild type. For instance, 76% of wild-
type dauers recovered from this stress, while only 22% of Dglo
did. This result shows that glyoxalases are required for survival
after desiccation stress.
How does DJ-1 contribute to survival under stress conditions?
DJ-1 is reported to exert its neuroprotective function in
mitochondria (Junn et al., 2009). Many genes involved in
Parkinson’s disease, among them DJ-1, have been linked to
alterations in mitochondrial structure and function and an
enhanced sensitivity to mitochondrial toxins like Complex-I
inhibitors (Clark et al., 2006; Park et al., 2006; Irrcher et al.,
2010; Kamp et al., 2010; Sai et al., 2012; Wang et al., 2012;
Burchell et al., 2013). Thus we decided to test the structure and
function of mitochondria in the absence of DJ-1 (DDdjr) or
complete glyoxalase activity (Dglo), as revealed by staining with
MitoTracker CMXRos (Fig. 2A) (Pendergrass et al., 2004). In
wild type (N2, top left), mitochondria exhibited elaborated
networks, whose intensity of staining represent mitochondrial
membrane potential (arrows, Fig. 2A) (Pendergrass et al., 2004).
Single mutant glod-4 or DDdjr greatly reduced networks. In the
triple mutant (Dglo) the staining and thus the membrane potential
of mitochondria was negligible, and only gut granules
(arrowheads) were visible. Thus we conclude that glyoxalases
are essential to maintain the mitochondrial structure, potential
and function under desiccation stress.
One possibility to explain the data so far presented is that the
lack of glyoxalases could lead to the build up of their substrates,
toxic aldehydes, leading to phenotypic alteration. However, we
propose another hypothesis: the defects may result not only from
a build up of toxic aldehydes, but also from the lack of the
enzymatic products themselves (a-hydroxyacids). To support this
idea, we looked at the effects of the products of glyoxalases, D-
lactic acid (DL) and glycolic acid (GA) (Thornalley, 2003; Lee
et al., 2012), on the structure and activity of mitochondria. There
is no easy way to supply these compounds to dauer larvae,
because they do not feed. Therefore we decided to use HeLa cells
Fig. 1. Glyoxalases are required for desiccation tolerance in the C.
elegans dauer larva. (A) Experimental procedure for preconditioning and
further desiccation of C. elegans dauer larvae. RH, relative humidity.
(B) Differential expression of djr-1.1, djr-1.2, and glod-4 genes in the C.
elegans dauer larva upon preconditioning. Tsp-21 gene was used as the
internal control. (C) Survival rates of desiccated dauer larvae. Columns show
the estimated means of triplicates. Blue, 98% RH; Red, 60% RH. Error bars,
standard error of the estimate. ***p,0.001.
Fig. 2. Glycolate and D-lactate are required for mitochondrial
membrane potential. (A) Disruption of the mitochondrial network upon
desiccation at 98% RH and rehydration in mutants for glyoxalases. Arrow,
mitochondrial networks stained with MitoTracker. Arrowhead, non-specific
staining of the gut granules. (B) JC-1 staining in live HeLa cells with 1 mM of
glycolate (GA), D-lactate (DL), and L-lactate (LL). Red, JC-1; blue, DNA. For
merged images and quantification, see Fig. 4. Scale bars: 10 mm.











as an alternative model for studying the role of glyoxalases in
mitochondrial function.
In HeLa cells, DJ-1 RNAi specifically decreased expression of
DJ-1 protein (supplementary material Fig. S2) and decreased
mitochondrial membrane potential as probed with a J-aggregate
forming lipophilic dye JC-1 (Fig. 2B) (Smiley et al., 1991),
consistent with the previous reports (Larsen et al., 2011; Giaime
et al., 2012; Heo et al., 2012). Remarkably, addition of 1 mM GA
or DL but not L-lactate (LL) restored mitochondrial membrane
potential, while these substances did not affect control Luciferase
(Luc) RNAi treated cells (Fig. 2B). These results suggest that GA
and DL, products of glyoxalases, are required for the activation or
maintenance of mitochondrial membrane potential.
Paraquat is an environmental poison known to affect
mitochondria (Palmeira et al., 1995); it has been implicated in
the onset of Parkinson’s disease, and has been shown to decrease
mitochondrial membrane potential (McCarthy et al., 2004;
Mitsopoulos and Suntres, 2011). In our assay, paraquat indeed
decreased mitochondrial membrane potential in both control and
DJ-1 RNAi cells as tested by JC-1 (Fig. 3A). Remarkably,
addition of GA or DL, but not LL, restored mitochondrial
membrane potential of the paraquat-treated cells. In addition to
affecting mitochondrial potential, paraquat also induces change in
mitochondrial structure (Ueda et al., 1985). Thus we imaged
structure of mitochondria in the presence of paraquat with
MitoTracker, as it robustly stained mitochondria in HeLa.
Although DJ-1 RNAi in HeLa cells did not produce an altered
mitochondrial structure (supplementary material Fig. S3),
together with a low dose of paraquat in DJ-1 RNAi cells,
mitochondria became more circular (Fig. 3B, insets). This
circular phenotype was also rescued by the addition of DL and
GA (Fig. 3B, insets; supplementary material Fig. S3).
Increasing doses of paraquat resulted in shorter lengths of wild-
type, DDdjr and glod-4 mutant reproductive larvae of C. elegans,
suggesting inhibition of development or growth of worms
(supplementary material Fig. S4A,B). DDdjr mutant exhibited
slightly increased sensitivity to paraquat (supplementary material
Fig. S4C). The decreased viability was rescued by addition of
GA (supplementary material Fig. S4C). Similar to human
cells, paraquat disrupted mitochondrial membrane potential in
reproductive larvae of C. elegans, which was rescued by the
addition of GA (Fig. 3C).
We wanted to test whether GA and DL can rescue a
mitochondrial defect caused by loss of other Parkinson’s genes,
i.e. PINK1 and Parkin. These genes are genetically and
functionally related to DJ-1 (Exner et al., 2007; Hao et al.,
2010; Irrcher et al., 2010). Because Parkin was not detected in
HeLa (Matsuda et al., 2010), PINK1 was investigated. The
protein was downregulated by RNAi (supplementary material
Fig. S5). PINK1 RNAi decreased mitochondrial membrane
potential, as reported previously (Exner et al., 2007).
Remarkably, GA and DL rescued this defect (Fig. 4A,B). In
addition, the substances restored mitochondrial membrane
potential of paraquat-treated PINK1 RNAi cells.
So far, we have shown that the addition of products of
glyoxalases can rescue lowered mitochondrial membrane
potential caused by downregulation of DJ-1 or PINK1 or by
environmental stress. But are GA and DL produced endogenously?
We asked whether activation of DJ-1, or glyoxylases in general,
during stress leads to a bulk accumulation of DL or GA. For this
Fig. 3. Glycolate and D-lactate rescue the stress-induced mitochondrial defects. (A) JC-1 staining in live esiRNA-transfected HeLa cells treated with
50 mM paraquat (PQ2+) and 1 mM of glycolate (GA), D-lactate (DL), and L-lactate (LL). Red, JC-1; blue, DNA. For merged images, see Fig. 4A. (B) Mitochondria
of paraquat-treated HeLa cells. Green, MitoTracker; Blue, DNA. Inset, 46magnification of the boxed area. (C) Mitochondria in worm glyoxalase mutant larvae.
Wild type (N2), DJ-1 mutant (DDdjr) and GLOD-4 mutant (glod-4) were treated with PQ2+ with or without 10 mM GA, and stained with MitoTracker (green).
Dashed lines show the outlines of larvae. Scale bars: 10 mm.











purpose, we looked for both these compounds in C. elegans as well
as in HeLa cells. By using a chiral column in an LC-MS
application, we could separate D- and L-lactate very effectively
(arrows in supplementary material Fig. S6A). In dauer larvae
before preconditioning, almost all of lactate was present as the L-
stereoisomer (supplementary material Fig. S6A). Preconditioning
did not increase D-lactate to any significant extent. Interestingly,
the amount of L-lactate decreased 3-fold, perhaps due to entry of
the metabolite into gluconeogenesis. We could not detect any GA
in the same amount of extract, while an increased amount of
trehalose was detected upon preconditioning, consistent with a
previous report (supplementary material Fig. S6B,C) (Erkut et al.,
2011). Thus we conclude that either these substances are transient
intermediates of a pathway needed for the activation of
mitochondria, or they are produced in very small amounts and
act as signaling molecules.
We have shown that the products of glyoxalases are required
for maintenance of mitochondrial potential in HeLa cells and C.
elegans. Because toxins that affect mitochondrial function can
hasten Parkinson’s disease (Bové et al., 2005), we wondered
whether GA and DL would protect neurons against mitochondrial
damage. We generated embryonic mesencephalic primary neuron
cultures and analyzed the survival of tyrosine hydroxylase-
positive (TH+) neurons by immunostaining. Strikingly the in vitro
survival of dopaminergic neurons was stimulated by GA, and DL,
but not by LL (Fig. 5A; supplementary material Fig. S7A).
Furthermore, GA and DL significantly rescued the toxic effect of
paraquat on the TH+ neurons (Fig. 5B). We also investigated the
effect of these substances on dopaminergic neurons from DJ-1
knock out mice (supplementary material Fig. S7B). Similarly, GA
and DL could stimulate neuronal survival. These results stress the
importance of GA and DL in survival of dopaminergic neurons.
DISCUSSION
In this paper, we have shown that the products of glyoxalases,
glycolate and D-lactate, are required to maintain mitochondrial
membrane potential. Maintenance of mitochondrial membrane
potential is associated with response to desiccation stress in
worms, and importantly, the survival of dopaminergic neurons in
mammals. Our data therefore highlight an understudied aspect of
the Embden–Meyerhof glycolytic pathway: A small fraction of
triose-phosphate is converted into methylglyoxal, which is further
transformed into D-lactate by glyoxalases (Thornalley, 2003). It
has so far been thought that glyoxalases protect cells by removing
Fig. 4. Glycolate and D-lactate rescue lowered mitochondrial membrane potential caused by silencing PINK1. (A) Merged images of JC-1 fluorescence
in live esiRNA-transfected HeLa cells. Blue, DNA; Green and red, mitochondria with low and high membrane potentials, respectively. Scale bars: 10 mm. (B) The
ratio of JC-1 fluorescence intensities in the individual cells. The column and the bar represent the mean and SD, respectively. n§6. *p,0.05; **p,0.01;
***p,0.001.











products of glycolysis or lipid oxidation. Thus, our data allow us
to suggest the idea that glyoxalases have two functions: on one
hand they detoxify chemically aggressive aldehydes and on the
other hand they produce compounds necessary for maintaining
mitochondrial potential.
DJ-1 is a member of a new class of glutathione-independent
glyoxalases that have recently been identified, and studies of their
enzymology are just beginning. In vitro enzyme assays using
NMR have shown that both human and C. elegans DJ-1 can
produce glycolic acid and lactate, but they did not distinguish
between L- and D-lactate (Lee et al., 2012). More recently,
studies on the biochemical activity of DJ-1 expressed in vitro,
using enzyme-coupled assays, suggest that it has only a weak
activity as a methylglyoxalase (Hasim et al., 2014). Indeed, our
measurements of D-lactate and glycolate (supplementary material
Fig. S6) show that they do not accumulate in high amounts, which
further suggests that they do not function in high concentration.
However, it is also possible that these glyoxalases use other
substrates more efficiently. Further studies will be required to
understand the in vivo regulation and activity of the DJ-1 family,
but this will require improved methods to detect flux through the
glyoxalase pathway in vivo. However, the facts that D-lactate and
glycolic acid have such an effect on mitochondria, and rescue the
DJ-1 phenotype, strongly suggest that these substances are
important products of the DJ-1 glyoxalase in vivo.
We do not yet understand how D-lactate and glycolate increase
or maintain mitochondrial potential. For instance it is quite
possible that these products are further processed. We know,
however, that GA and DL restore mitochondrial membrane
potential in cells depleted of DJ-1, PINK1 or treated with
paraquat. Thus, GA and DL are core compounds in a general
pathway that maintains mitochondrial potential. Because both
paraquat and loss of DJ-1 are thought to increase permeability of
the inner mitochondrial membrane (Costantini et al., 1995;
Giaime et al., 2012), one possibility is that GA and DL decrease
permeability of the mitochondrial membrane under stressed
conditions. Understanding this molecular mechanism is an
avenue for future investigation.
It seems likely that the symptoms of Parkinson’s disease,
neuronal cell death in the substantia nigra, arise from an
increased sensitivity of dopaminergic neurons to diminished
mitochondrial membrane potential (Corti et al., 2011; Federico
et al., 2012). A decline in mitochondrial activity would therefore
tend to exacerbate this problem. Indeed, recent experiments in
C. elegans show that mitochondria are required for survival of
neurons (Rawson et al., 2014). Further investigation of the
phenotypes we observe should clarify which aspects of cellular
metabolism require mitochondrial potential. Our data show that
there is no reduction in ATP levels in DJ-1 mutant conditions,
suggesting that it is not an energy requirement (data not shown).
Rather, other mitochondrial metabolism cycles, such as one-
carbon metabolism (Tibbetts and Appling, 2010; Locasale, 2013)
may be involved. Other pathways, such as the glyoxylate shunt in
worms, may also play a role.
Therapeutic routes for Parkinson’s disease have so far
been symptomatic and intractable. It has been shown that
environmental toxins that affect mitochondria are strongly
linked to the appearance of Parkinson’s disease (Song et al.,
2004; Freire and Koifman, 2012) and impairment of the
mitochondrial function is a common feature of both idiopathic
and genetic Parkinson’s disease (Schapira et al., 1989; Clark
et al., 2006; Park et al., 2006; Irrcher et al., 2010; Kamp et al.,
2010; Pan-Montojo et al., 2012; Wang et al., 2012; Braidy et al.,
2014; Burchell et al., 2013). Our discovery that the production of
molecules from endogenous enzymatic pathways can protect
neurons, offers a potential therapeutic direction that could include
preventive strategies. Both products of glyoxalases exist in many
natural products. Thus, providing neurons with these substances
might protect them against metabolic or environmental
stress. Because many diseases are associated with a decline in
mitochondrial activity (Schapira, 2012), the products of




Glucose (Merck), glycolic acid (15451, ACROS Organics) neutralized
with NaOH to pH57.4, and sodium D-lactate (71716, Sigma), glyoxal
(128465, Sigma), paraquat (sc-257968, SantaCruz biotechnologies or
36541 FlukaH from Sigma–Aldrich) were used.
Cell culture, RNAi, worm strains
HeLa cells were maintained in DMEM (Life Technologies)
supplemented with 10% fetal bovine serum (FBS), 2 mM GlutaMAX,
100 unit/ml penicillin, 100 mg/ml streptomycin at 37 C̊ in a 5%
CO2 environment. HeLa cells were RNAi-transfected with 10 nM
Fig. 5. Glycolate and D-lactate support viability of dopaminergic
neurons in vitro. (A) Viability of the dopaminergic neurons in vitro from wild-
type and DJ-1 mutant mice embryos in the presence or absence of 10 mM
glycolate (GA), D-lactate (DL), or L-lactate (LL). Points show the ratio of
tyrosine hydroxylase-positive (TH+) cells to the control (no supplement).
Horizontal blue bars and error bars represent the mean and SD, respectively.
**p,0.01; ***p,0.001. (B) Viability of the dopaminergic neurons in the
presence of 12.5 mM paraquat (PQ2+) in the absence or presence of 10 mM
GA, DL, or LL. Primary neurons isolated from wild-type E14.5 embryos were
cultured in vitro in the presence of the indicated supplements and PQ2+.
Points show the ratio of TH+ cells to the control. Horizontal blue bars and
error bars represent the mean and SD, respectively.











endoribonuclease-digested small interfering RNA (MISSION esiRNA,
Sigma) using Oligofectamine RNAi MAX reagent (Invitrogen). Cells
were assayed after 48 hours from RNAi.
All C. elegans strains were maintained on NGM agar plates seeded
with Escherichia coli NA22 at 15 C̊ (Brenner, 1974). Mutant strains djr-
1.1(tm918), djr-1.2(tm951) and glod-4(tm1266) were obtained from
National Bioresource Project, Japan. Wild-type (N2) and daf-2(e1370)
mutant strains were obtained from Caenorhabditis Genetics Center,
USA. All mutants were outcrossed at least twice with the wild type to
eliminate background mutations.
Preparation, culture and treatment of primary mesencephalic
dopaminergic neurons from mouse embryos
Primary mesencephalic neuronal cell cultures were prepared as previously
described (Gille et al., 2004). Briefly, brain mesencephalons from E14.5
C57JBL6 or DJ-1 embryos were dissected under the microscope and
digested with Trypsin-EDTA (Sigma–Aldrich). The trypsin reaction was
stopped by adding the basic medium (BM) containing Neurobasal A
medium (Gibco), 1 mg/ml penicillin/streptomycin, 10% (v/v) fetal calf
serum (Invitrogen) and 2 mM L-Glutamine and cells were mechanically
dissociated using a fire-polished Pasteur pipette. Medium was fully
replaced by centrifuging for 5 minutes at 1200 rpm, aspiring the
supernatant and adding 8 ml of the fresh BM to the pellet. Concentration
of cells in the medium was estimated and cells were plated in a volume of
250 ml in 4-well plates (176740, Nunc, Thermo Scientific) or 35 ml in m-
clear 96-well plates (Greiner) coated with poly-D-lysine (Sigma–Aldrich)
at a concentration of 26106 cells per ml. The same volume of medium
containing the different treatment substances was added 4 hours after
plating to obtain the following treatment concentrations: control, 10 mM
GA, 10 mM DL and 10 mM LL. 24 hours later 1/3 of the medium was
replaced with fresh BM. On DIV3 (day-in-vitro-culture 3) half of the
medium was replaced with B27 medium containing Neurobasal A medium,
1 mg/ml penicillin/streptomycin, 2 mM L-Glutamine (Sigma–Aldrich) and
B-27 supplement (Life Technologies) and on DIV5 all medium was
replaced by B27 medium. On DIV7 cell were either fixed using AccustainH
(Sigma–Aldrich) for 30 minutes or PQ2+ treated at a concentration of
12.5 mM for 72 hours more and fixed. All animal experiments were
performed in accordance with German animal welfare legislation.
Immunocytology of mesencephalic cell cultures
AccustainH fixed neuronal cell cultures were washed 36 10 minutes in
phosphate buffered saline (PBS), blocked using a blocking solution (BS)
(0.2% Triton X-100 in PBS and 5% donkey serum (DS)) for 1 hour at
RT, and incubated with mouse anti-TH (1:500, Millipore), chicken anti-
bIII-tubulin (1:500, Millipore) and rabbit anti-TOM20 (1:200, FL-145,
Santa Cruz Biotechnology) or rabbit anti-NeuN (1:500, Millipore)
primary antibodies in BS overnight at 4 C̊. On the next day cells
were washed 4610 minutes with PBS, incubated in donkey AlexaH 488
anti-rabbit, donkey AlexaH 555 anti-mouse (Life Technologies) and
donkey AlexaH 647-anti-chicken (Jackson Immunoresearch) secondary
antibodies for 1 hour at RT, washed 4610 minutes with PBS, incubated
with Hoechst33342 for 10 minutes and washed once more in PBS.
Generation of C. elegans multiple mutant strains
djr-1.1 and djr-1.2 males and hermaphrodites were first crossed
reciprocally. L4 hermaphrodites from the F1 generation were singled
out and let lay eggs for 2 days. Subsequently, the adults were lysed and
genotyped individually.
One adult was put in 100 ml lysis buffer (16PCR buffer and 200 ng/ml
proteinase-K in water), snap-frozen in liquid nitrogen and incubated for
1 hour at 65 C̊. Then, the enzyme was denatured at 98 C̊ for 15 minutes.
Genotyping PCR was performed in 16PCR buffer with MgCl2, 200 mM
dNTP mix, 400 nM of each primer, 0.02 U Taq polymerase and 5 ml of
gDNA from the lysis of an adult hermaphrodite using the primers listed
in supplementary material Table S1. PCR conditions were the following:
Initial denaturation at 94 C̊ for 10 minutes, amplification in 30 cycles of
94 C̊ for 30 seconds, 62 C̊ for 25 seconds and 72 C̊ for 30 seconds, final
extension at 72 C̊ for 10 minutes.
Populations arising from an individual heterozygous for both alleles
were selected and L4 hermaphrodites were singled out for one more
round of genotyping as described above. Finally, 3 lines homozygous for
both alleles were found. One of these lines was selected to be used in
subsequent experiments. We named this double mutant DDdjr.
As a next step, DDdjr mutants were crossed with glod-4(tm1266)
mutants. The genotyping and selection of homozygous triple mutants
were done similarly, using the primers listed in supplementary material
Table S1. PCR conditions were the same as above, except that the
annealing temperature was increased to 65 C̊. Finally, two lines
homozygous for all 3 alleles were obtained. One of these lines was
used in experiments. For convenience, we named this triple mutant Dglo.
Desiccation and measurement of desiccation tolerance in
dauers
N2, glod-4, DDdjr and Dglo dauers were generated on agarose plates by
sterol depletion/lophenol substitution (Matyash et al., 2004). daf-2 dauers
were generated in liquid culture by growing at 25 C̊. Worms were
preconditioned at 98% RH for 4 days and/or desiccated at 60% RH for 1
day in controlled humidity chambers (Erkut et al., 2013). Survival rate of
different strains were calculated as the percentage of survivors in the total
population after rehydration.
Measurement of desiccation-induced gene expression
Total RNA was extracted from daf-2 dauers before and after
preconditioning in 4 biological replicates. 500 ng of total RNA was
reverse transcribed using 250 ng oligo(dT)12–18 primer (Invitrogen, CA),
5 nmol dNTP and 200 U SuperScript III reverse transcriptase
(Invitrogen, CA) at 50 C̊ for 1 h according to the protocol supplied by
the manufacturer. PCR was performed in 16 PCR buffer with MgCl2,
200 mM dNTP, 500 nM of forward and reverse primers, and 0.05 U Taq
polymerase, using 0.1 ml of the cDNA product. PCR conditions were the
following: 94 C̊ for 10 minutes, 30 cycles of 94 C̊ for 20 seconds, 61.5 C̊
for 25 seconds and 72 C̊ for 15 seconds, finally 72 C̊ for 5 minutes. The
primer sequences are presented in supplementary material Table S1. PCR
products are separated on a 3% agarose gel and visualized using ethidium
bromide.
Paraquat treatment of HeLa cells and worm larvae
For experiments with paraquat (PQ2+) in cells, 50 mM PQ2+ and 1 mM
GA/DL/LL were added to HeLa cells and incubated for 24 hours. The
media and the supplements were replaced 1 hour before fixation or assay.
Worms were treated with 200 mM PQ with or without 10 mM GA, and
compared to worms that are not treated with either PQ or GA.
Subsequently, they were stained and imaged for mitochondrial
organization and activity.
Mitochondrial live staining of worm larva
Mitochondrial staining was performed as previously described (Yang and
Hekimi, 2010). Briefly, Mitotracker Deep Red and CMXROS (M22426,
M7512, Life Technologies) were dissolved in DMSO at a concentration
of 5 mM and kept at 220 C̊ as a stock solution. On the day of
microscopy worms were incubated in a 1:1000 diluted Mitotracker for
45 minutes at room temperature. Worms were then paralyzed with 1 mM
Levamizol (Sigma–Aldrich), placed on slides covered with a thin layer of
NGM medium on top of which the coverslip (22622 mm, Menzel–Glaser
no. 1) was fixed using nail polish.
Light microscopy, and image analysis
To image mitochondria of HeLa cells, MitoTracker Red CMXRos was
added at 150 nM and fixed with 3% (v/w) paraformaldehyde in PBS, 1 mM
MgCl2, and 5 mM EGTA. DNA was counter-stained by 1 mg/ml
Hoechst33342. As MitoTracker Red CMXRos robustly stained
mitochondria in HeLa, JC-1 (Santa Cruz Biotechnology, 10 mg/ml) was
used to visualize mitochondrial membrane potentials in live cells, with
100 ng/ml Hoechst33342. They were imaged on the DeltaVision system
(Applied Precision Inc., Issaquah, WA, USA) using a 606 objective
(PlanApo N, NA51.42, Olympus) equipped with a CO2 supply, and











deconvolved and maximally projected images were used for the analysis.
Due to high background of MitoTracker in the center of the cell,
mitochondria in a 15615-mm area in the periphery were manually annotated
on ImageJ software. Total integrated intensity of green- and red-fluorescent
JC-1 in the individual cells was measured to obtain the fluorescence ratio.
All JC-1 images were adjusted for the contrast in the same way on ImageJ.
Microscopy images from live paralyzed worm larvae stained with
Mitotracker were taken using a confocal microscope (LSM510, Zeiss,
Germany). Samples were excited using a 514 (Mitotracker CMXRos) or a
647 (Mitotracker Deep Red) nm lasers and two channels, one BP505-550
or LP650 and the BF channel were used to acquire the images. Gain was
maintained between 450 and 515 for all samples to ensure the detection
of signal intensity differences.
Counting of dopaminergic neurons
Dopaminergic TH+ neurons were observed using an inverted
fluorescence microscope (Axiovert 200M, Zeiss) under a 106 objective
(PlanApo, NA50.45). The diameter of every well was scanned in two
perpendicular directions (i.e. top to bottom and left to right) and total
TH+ neurons were counted for every well.
Immunoblotting
EsiRNAi-transfected HeLa and mouse brains were lysed in a lysis buffer
(50 mM HEPES pH57.5, 150 mM KCl, 1 mM MgCl2, 10% glycerol,
0.1% NP-40) with a protease inhibitor cocktail (Complete, Roche),
resolved in SDS-PAGE, and transferred onto a nitrocellulose membrane.
In immunoblotting, the following primary antibodies were used: human
DJ-1 (FL-189, SantaCruz, 1:200 dilution); mouse DJ-1 (HPA004190,
Sigma, 1:250); PINK1 (38CT20.8.5, Thermo, 1:500); alpha-tubulin
(DM1A, Sigma, 1:2000). Horseradish peroxidase-conjugated anti-IgG
antibodies (Bio-Rad, 1:2000) were used for the secondary antibody.
Chemiluminescence by ECL reagent was developed on a Hyperfilm (GE
Healthcare).
Liquid chromatography mass spectrometry (LC-MS) analysis of
alpha-hydroxy acids
daf-2 dauers directly collected from the liquid culture or preconditioned
at 98% RH for 4 days were homogenized and extracted according to
Bligh’s and Dyer’s method (Bligh and Dyer, 1959). The aqueous phases
were dried and dissolved again in 50% methanol (v/v) using volumes
calculated according to total soluble protein amounts. HeLa cells
harvested directly or treated with GA were also extracted by the same
method. The final volume of their aqueous fractions was normalized
according to the number of cells.
Separation and detection of glycolic and lactic acids were performed
by normal-phase LC-MS using an Agilent G1312A pump equipped with
an Agilent Autosampler G1329A. Separation employed a Cogent
Diamond Hydride column (25 cm64.6 mm i.d., 4 mm, Microsolv)
coupled on-line to a Waters/Micromass LCT time of flight (TOF) mass
spectrometer equipped with electrospray ionization (ESI). Alpha-hydroxy
acid species were separated by isocratic elution. An aqueous formic acid
(0.1%; v/v), including 10 mM ammonium formate/acetonitrile mixture
(30:70; v/v) was used. The column was operated at 40 C̊ and flow rate
was set to 1 ml/minute with a split to 100 ml/minute into the mass
spectrometer. 5 ml of each sample were injected into the column.
For the separation of D- and L-lactic acid enantiomers, we employed
chiral chromatography by using an Astec CHIROBIOTIC R chiral
column (25 cm64.6 mm i.d., 5 mm, Supelco), as reported previously
(Henry et al., 2012). Isocratic elution was performed with the mobile
phase 15% (v/v) 30 mM ammonium acetate in H2O (adjusted with acetic
acid to pH 3) and 85% (v/v) acetonitrile. The column was operated at 5 C̊
with a split to 50 ml/minute into the same mass spectrometer.
The mass spectrometer was operated with a spray voltage of 2.5 kV
and a source temperature of 140 C̊ in negative and positive ion mode.
Nitrogen was used as the cone and nebulizing gas at flow rates of
approximately 40 and 500 L/h, respectively. Positive and negative ion
full scan mass spectra were acquired from the m/z range of 60–1000 mass
units in a scan time of 1 second. The system was operated and the
resulting data were processed by MassLynx (Version 4.1) software
(Waters).
Statistics and graph representation
Statistical differences between the tested treatments were determined by
ANOVA followed by the Tukey’s honestly significant differences post-
hoc test. Survival rates were compared using beta regression (Erkut et al.,
2013). Data expressed in percentages were first transformed by Tukey’s
double arcsine function (Freeman and Tukey, 1950) to achieve normal
distribution prior to ANOVA. Statistical analysis and graphs were done
on a Prism software version 5 (GraphPad Inc.) and an R environment.
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